• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期前列腺癌的传统与新型成像方式:批判性综述

Traditional and novel imaging modalities for advanced prostate cancer: A critical review.

作者信息

Hill Spencer, Kassam Farzaan, Verma Sadhna, Sidana Abhinav

机构信息

Department of Urology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

出版信息

Urol Ann. 2023 Jul-Sep;15(3):249-255. doi: 10.4103/UA.UA_170_20. Epub 2023 Jul 17.

DOI:10.4103/UA.UA_170_20
PMID:37664103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10471808/
Abstract

Accurate detection of metastatic prostate cancer in the setting of preoperative staging as well as posttreatment recurrence is crucial to provide patients with appropriate and timely treatment of their disease. This has traditionally been accomplished with a combination of computed tomography, magnetic resonance imaging, and bone scan. Recently, more novel imaging techniques have been developed to help improve the detection of advanced and metastatic prostate cancer. This review discusses the efficacy of the traditional imaging modalities as well as the novel imaging techniques in detecting metastatic prostate cancer. Articles discussed were gathered through a formal PubMed search.

摘要

在术前分期以及治疗后复发的情况下准确检测转移性前列腺癌,对于为患者提供适当且及时的疾病治疗至关重要。传统上,这是通过计算机断层扫描、磁共振成像和骨扫描相结合来完成的。最近,已经开发出了更新颖的成像技术,以帮助提高对晚期和转移性前列腺癌的检测。本综述讨论了传统成像方式以及新型成像技术在检测转移性前列腺癌方面的功效。所讨论的文章是通过正式的PubMed搜索收集的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e8/10471808/f332bc632640/UA-15-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e8/10471808/f332bc632640/UA-15-249-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1e8/10471808/f332bc632640/UA-15-249-g001.jpg

相似文献

1
Traditional and novel imaging modalities for advanced prostate cancer: A critical review.晚期前列腺癌的传统与新型成像方式:批判性综述
Urol Ann. 2023 Jul-Sep;15(3):249-255. doi: 10.4103/UA.UA_170_20. Epub 2023 Jul 17.
2
A Prospective Comparison of F-prostate-specific Membrane Antigen-1007 Positron Emission Tomography Computed Tomography, Whole-body 1.5 T Magnetic Resonance Imaging with Diffusion-weighted Imaging, and Single-photon Emission Computed Tomography/Computed Tomography with Traditional Imaging in Primary Distant Metastasis Staging of Prostate Cancer (PROSTAGE).F-前列腺特异性膜抗原-1007 正电子发射断层扫描计算机断层扫描、全身 1.5T 磁共振成像弥散加权成像与传统成像单光子发射计算机断层扫描/计算机断层扫描在前列腺癌原发远处转移分期(PROSTAGE)中的前瞻性比较
Eur Urol Oncol. 2021 Aug;4(4):635-644. doi: 10.1016/j.euo.2020.06.012. Epub 2020 Jul 13.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer.前列腺癌术前分期及再分期管理中的先进成像技术。
Int J Urol. 2019 Jan;26(1):18-30. doi: 10.1111/iju.13797. Epub 2018 Sep 20.
5
Comparison of cross-sectional imaging techniques for the detection of prostate cancer lymph node metastasis: a critical review.用于检测前列腺癌淋巴结转移的横断面成像技术比较:一项批判性综述
Transl Androl Urol. 2020 Jun;9(3):1415-1427. doi: 10.21037/tau.2020.03.20.
6
How PET-CT is Changing the Management of Non-metastatic Castration-resistant Prostate Cancer?: Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration ?正电子发射断层扫描-计算机断层扫描如何改变去势抵抗性前列腺癌的治疗管理?:Comment la TEP-TDM Peut Modifier la Prise en Charge du Cancer de la Prostate Non Métastatique Résistant à la Castration?
Prog Urol. 2022 Jun;32(6S1):6S43-6S53. doi: 10.1016/S1166-7087(22)00174-9.
7
Novel Imaging in Detection of Metastatic Prostate Cancer.新型影像学在转移性前列腺癌检测中的应用。
Curr Oncol Rep. 2019 Mar 5;21(4):31. doi: 10.1007/s11912-019-0780-8.
8
Managing Nonmetastatic Castration-resistant Prostate Cancer.管理非转移性去势抵抗性前列腺癌。
Eur Urol. 2019 Feb;75(2):285-293. doi: 10.1016/j.eururo.2018.07.035. Epub 2018 Aug 14.
9
Positron emission tomography for prostate, bladder, and renal cancer.用于前列腺癌、膀胱癌和肾癌的正电子发射断层扫描。
Semin Nucl Med. 2004 Oct;34(4):274-92. doi: 10.1053/j.semnuclmed.2004.06.004.
10
Lymph node imaging in initial staging of prostate cancer: An overview and update.前列腺癌初始分期中的淋巴结成像:综述与更新
World J Radiol. 2017 Oct 28;9(10):389-399. doi: 10.4329/wjr.v9.i10.389.

引用本文的文献

1
Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse.前列腺癌复发的影像学评估:局部和全身复发检测的进展
Abdom Radiol (NY). 2025 Feb;50(2):807-826. doi: 10.1007/s00261-024-04412-7. Epub 2024 Sep 10.
2
Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation Planning.在前列腺特异性膜抗原(PSMA)扫描分期中区分生理性输尿管摄取与受累淋巴结:对放射治疗计划的影响。
Cureus. 2024 Jun 25;16(6):e63105. doi: 10.7759/cureus.63105. eCollection 2024 Jun.

本文引用的文献

1
The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa).多参数磁共振成像(mpMRI)在临床上显著前列腺癌(csPCa)的检测、评估和监测中的应用。
Curr Urol Rep. 2019 Sep 2;20(10):60. doi: 10.1007/s11934-019-0926-0.
2
Comparison of 18F-Fluciclovine PET/CT and 99mTc-MDP bone scan in detection of bone metastasis in prostate cancer.18F-氟西克洛维PET/CT与99mTc-MDP骨扫描在前列腺癌骨转移检测中的比较
Nucl Med Commun. 2019 Sep;40(9):940-946. doi: 10.1097/MNM.0000000000001051.
3
Molecular Imaging of Recurrent and Metastatic Prostate Cancer.
前列腺癌复发和转移的分子影像学
Semin Nucl Med. 2019 Jul;49(4):280-293. doi: 10.1053/j.semnuclmed.2019.02.005. Epub 2019 Mar 21.
4
Novel Imaging in Detection of Metastatic Prostate Cancer.新型影像学在转移性前列腺癌检测中的应用。
Curr Oncol Rep. 2019 Mar 5;21(4):31. doi: 10.1007/s11912-019-0780-8.
5
Fluciclovine positron emission tomography in the setting of biochemical recurrence following local therapy of prostate cancer.氟代脱氧胸苷正电子发射断层扫描在前列腺癌局部治疗后生化复发中的应用
Transl Androl Urol. 2018 Oct;7(5):824-830. doi: 10.21037/tau.2018.07.17.
6
68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.68Ga-PSMA PET/CT 在前列腺癌患者中的应用——疾病的表现形式、良性发现和误区。
Cancer Imaging. 2018 Nov 1;18(1):39. doi: 10.1186/s40644-018-0175-3.
7
A Prospective Comparison of F-Sodium Fluoride PET/CT and PSMA-Targeted F-DCFBC PET/CT in Metastatic Prostate Cancer.F-氟钠 PET/CT 与 PSMA 靶向 F-DCFBC PET/CT 对转移性前列腺癌的前瞻性比较
J Nucl Med. 2018 Nov;59(11):1665-1671. doi: 10.2967/jnumed.117.207373. Epub 2018 Mar 30.
8
Imaging the High-risk Prostate Cancer Patient: Current and Future Approaches to Staging.对高危前列腺癌患者进行成像:当前及未来的分期方法
Urology. 2018 Jun;116:3-12. doi: 10.1016/j.urology.2017.12.001. Epub 2018 Mar 12.
9
Update on F-Fluciclovine PET for Prostate Cancer Imaging.氟[^18^F]氟代脱氧葡萄糖 PET 用于前列腺癌成像的最新进展。
J Nucl Med. 2018 May;59(5):733-739. doi: 10.2967/jnumed.117.204032. Epub 2018 Mar 9.
10
Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options.临床局限性前列腺癌:AUA/ASTRO/SUO 指南。第 I 部分:风险分层、共同决策和治疗选择。
J Urol. 2018 Mar;199(3):683-690. doi: 10.1016/j.juro.2017.11.095. Epub 2017 Dec 15.